Related Experiment Video
Updated: Feb 23, 2026
07:40
Visualizing Scar Development Using SCAD Assay - An Ex-situ Skin Scarring Assay
Published on: April 28, 2022
3.3K
Predictive value of serum markers for postacne scarring
Abdel Aziz El-Taweel1, Rehab Mohammed Salem1, Ola S El-Shimi2
1Dermatology and Andrology, Faculty of Medicine, Benha University, Benha, Egypt.
Journal of Cosmetic Dermatology
|September 1, 2017
Summary
Serum hepcidin and C-reactive protein (CRP) levels can help predict postacne scarring. Lower hepcidin and higher CRP indicate a greater likelihood of developing acne scars.
Area of Science:
- Dermatology
- Biochemistry
- Clinical Medicine
Background:
- Postacne scarring is a significant concern for acne patients.
- Predicting scarring risk can improve acne management and prevent disfigurement.
Purpose of the Study:
- To investigate serum hepcidin and C-reactive protein (CRP) as potential biomarkers for predicting postacne scarring.
- To assess the correlation between serum hepcidin and CRP levels and the presence of postacne scars.
Main Methods:
- Studied 60 patients with moderate to severe acne vulgaris, identifying 35 with postacne scars.
- Quantified serum C-reactive protein (CRP) using latex agglutination turbidimetry.
- Measured serum hepcidin concentration via a double-antibody sandwich enzyme-linked immunosorbent assay (ELISA).
Main Results:
- Patients with postacne scars exhibited significantly lower serum hepcidin levels (P < .001).
- Elevated serum C-reactive protein (CRP) levels were significantly associated with postacne scarring (P < .05).
Conclusions:
- Serum hepcidin and CRP levels show potential as objective predictive markers for postacne scarring.
- These biomarkers could aid in identifying individuals at higher risk for developing acne scars, guiding treatment strategies.
More Related Videos
Related Concept Videos
01:19Clinical Applications of Epidermal Stem Cells
3.3K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
3.3K
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
973
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
973
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
633
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
633